These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 9486396

  • 1. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
    Sampaio EP, Moraes MO, Nery JA, Santos AR, Matos HC, Sarno EN.
    Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
    [Abstract] [Full Text] [Related]

  • 2. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY, Achirafi A, Flageul B.
    Acta Leprol; 2003 Feb; 12(3):117-22. PubMed ID: 15040702
    [Abstract] [Full Text] [Related]

  • 3. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
    Negera E, Walker SL, Bobosha K, Bekele Y, Endale B, Tarekegn A, Abebe M, Aseffa A, Dockrell HM, Lockwood DN.
    Front Immunol; 2018 Feb; 9():189. PubMed ID: 29479352
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy.
    Nery JA, Perissé AR, Sales AM, Vieira LM, Souza RV, Sampaio EP, Sarno EN.
    Indian J Lepr; 2000 Feb; 72(4):457-67. PubMed ID: 11212480
    [Abstract] [Full Text] [Related]

  • 6. Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients.
    Moraes MO, Sarno EN, Teles RM, Almeida AS, Saraiva BC, Nery JA, Sampaio EP.
    J Invest Dermatol; 2000 Dec; 115(6):935-41. PubMed ID: 11121122
    [Abstract] [Full Text] [Related]

  • 7. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.
    Sampaio EP, Kaplan G, Miranda A, Nery JA, Miguel CP, Viana SM, Sarno EN.
    J Infect Dis; 1993 Aug; 168(2):408-14. PubMed ID: 8335978
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor production in patients with leprosy.
    Barnes PF, Chatterjee D, Brennan PJ, Rea TH, Modlin RL.
    Infect Immun; 1992 Apr; 60(4):1441-6. PubMed ID: 1548069
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA, Kifayet A, Shahid F, Lateef A, Chiang J, Hussain R.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Is pentoxifylline a viable alternative in the treatment of ENL?
    Sarno EN, Nery JA, Garcia CC, Sampaio EP.
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):570-1. PubMed ID: 8642222
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
    Sales AM, de Matos HJ, Nery JA, Duppre NC, Sampaio EP, Sarno EN.
    Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.
    Sarno EN, Grau GE, Vieira LM, Nery JA.
    Clin Exp Immunol; 1991 Apr; 84(1):103-8. PubMed ID: 2015700
    [Abstract] [Full Text] [Related]

  • 16. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum.
    Santos DO, Suffys PN, Bonifácio K, Marques MA, Sarno EN.
    Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):199-203. PubMed ID: 8500267
    [Abstract] [Full Text] [Related]

  • 17. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
    Foss NT, de Oliveira EB, Silva CL.
    Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.